GARY RISKO: Open Payments
NPI 1467559682 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,421 in 144 payments from 16 companies in 2025. Trend: 2023 $1,818 · 2024 $2,614 · 2025 $2,421
Food & beverage: $2,368Education: $53
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $476 |
| Galderma Laboratories, L.P. | 21 | $354 |
| ABBVIE INC. | 23 | $314 |
| Janssen Biotech, Inc. | 19 | $261 |
| Novartis Pharmaceuticals Corporation | 18 | $258 |
| E.R. Squibb & Sons, L.L.C. | 11 | $227 |
| Lilly USA, LLC | 13 | $212 |
| PFIZER INC. | 6 | $94 |
| LEO Pharma Inc. | 3 | $65 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
Products named: Bimzelx, NEMLUVIO, TREMFYA, Sotyktu, SKYRIZI, TALTZ, COSENTYX, RINVOQ.
Industry payments across PA — which companies pay providers there.
